TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Little Green Pharma Ltd. ( (AU:LGP) ) just unveiled an announcement.
Little Green Pharma Ltd announced changes in director interests for Mr. Michael Lynch-Bell and Dr. Neale Fong, highlighting past non-disclosures due to administrative oversight. The company reassured stakeholders that it has adequate reporting practices to comply with ASX disclosure requirements and views the incident as isolated, with no impact on its operational integrity or market positioning.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd (ASX:LGP) is a leading global medicinal cannabis company with vertically integrated operations across Europe and Australia. The company offers a diverse portfolio of cannabis-based medicines distributed across Australia and over 12 export markets. It operates three production facilities in Denmark and Australia, including the largest facility in Europe, and is a top supplier in Australia, France, Germany, and the UK.
Average Trading Volume: 110,614
Technical Sentiment Signal: Hold
Current Market Cap: A$35.06M
Find detailed analytics on LGP stock on TipRanks’ Stock Analysis page.